Originally published In Press as doi:10.1074/jbc.M000687200 on April 25, 2000
J. Biol. Chem., Vol. 275, Issue 29, 21946-21952, July 21, 2000
GRB2 Links Signaling to Actin Assembly by Enhancing
Interaction of Neural Wiskott-Aldrich Syndrome Protein (N-WASp)
with Actin-related Protein (ARP2/3) Complex*
Marie-France
Carlier
§,
Pierre
Nioche¶
,
Isabelle
Broutin-L'Hermite¶,
Rajaa
Boujemaa
,
Christophe
Le
Clainche
,
Coumaran
Egile**,
Christiane
Garbay
,
Arnaud
Ducruix¶,
Philippe
Sansonetti**, and
Dominique
Pantaloni
From the
Dynamique du Cytosquelette,
¶ Cristallographie et RMN Biologiques, Laboratoire d'Enzymologie
et Biochimie Structurale, CNRS 91198 Gif-sur-Yvette,
** Pathogénicité Microbienne Moléculaire, Institut
Pasteur, 28 Rue du Dr Roux, 75 724 Paris and

INSERM U 266/UMR CNRS 8600, Faculté
de Pharmacie, 4 Avenue de l'Observatoire, 75248 Paris, France
Received for publication, January 24, 2000, and in revised form, March 30, 2000
 |
ABSTRACT |
Proteins of the Wiskott-Aldrich Syndrome protein
(WASp) family connect signaling pathways to the actin
polymerization-driven cell motility. The ubiquitous homolog of WASp,
N-WASp, is a multidomain protein that interacts with the Arp2/3 complex
and G-actin via its C-terminal WA domain to stimulate actin
polymerization. The activity of N-WASp is enhanced by the binding of
effectors like Cdc42-guanosine 5'-3-O-(thio)triphosphate,
phosphatidylinositol bisphosphate, or the Shigella IcsA
protein. Here we show that the SH3-SH2-SH3 adaptor Grb2 is another
activator of N-WASp that stimulates actin polymerization by increasing
the amount of N-WASp·Arp2/3 complex. The concentration dependence of
N-WASp activity, sedimentation velocity and cross-linking experiments
together suggest that N-WASp is subject to self-association, and Grb2
enhances N-WASp activity by binding preferentially to its active
monomeric form. Use of peptide inhibitors, mutated Grb2, and isolated
SH3 domains demonstrate that the effect of Grb2 is mediated by the
interaction of its C-terminal SH3 domain with the proline-rich region
of N-WASp. Cdc42 and Grb2 bind simultaneously to N-WASp and enhance
actin polymerization synergistically. Grb2 shortens the delay preceding the onset of Escherichia coli (IcsA) actin-based
reconstituted movement. These results suggest that Grb2 may activate
Arp2/3 complex-mediated actin polymerization downstream from the
receptor tyrosine kinase signaling pathway.
 |
INTRODUCTION |
Actin polymerization is the primary process that elicits the
motile response of living cells to extracellular stimuli such as
hormones or growth factors. Recent works have shown that the Arp2/3
complex, which contains 7 polypeptides including the actin-related proteins Arp2 and Arp3, is the universal downstream cytoskeletal target
of a variety of signaling cascades (see Refs. 1 and 2 for reviews). The
Arp2/3 complex stimulates the formation of new actin filaments that
actively grow from their barbed ends at specified locations beneath the
plasma membrane. Barbed end growth develops the protrusive force
responsible for lamellipodia extension and ruffling. The recent
reconstitution of actin-based motility from pure proteins (3) has
demonstrated that in addition to the site-directed nucleating activity
of activated Arp2/3, the maintenance of a highly dynamic steady state
of actin assembly in the medium by actin depolymerizing factor/cofilin
and capping proteins was crucial in eliciting actin-based movement.
The actin nucleating activity of Arp2/3 is revealed upon interaction
with proteins of the
WASp1/Scar family (4-9, see
Ref. 10 for review). These multidomain proteins are thought to connect
the signaling pathways to Arp2/3 and actin and are involved in the
formation of filopodia (11), lamellipodia (12), and podosomes (13).
However, the nature of the connections is not completely understood.
All proteins of the WASp/Scar family (14-17) contain an N-terminal
pleckstrin homology/WASp homology 1 (PH/WH1) domain, a proline-rich
region, and a C-terminal domain
WH2-Acidic (WA) which consists of a
verprolin/WASp homology 2 (WH2) domain, a short so-called
cofilin homology sequence, and an acidic extreme C-terminal
region. The PH/WH1 domain contains binding sites for WASp-interacting
protein (18), a homolog of the actin-binding protein End5p/verprolin in
yeast (19, 20), and for F-actin (9) and may also be responsible for
membrane attachment and PIP2 binding (6). The proline-rich
region has been shown to bind receptor tyrosine kinases Fgr and Fyn and
the SH2/SH3 domain-containing adaptors Grb2 and Nck, via their SH3 domains (21-25). The WA domain of all members of the WASp family is
responsible for the stimulation of actin nucleation by Arp2/3 complex
and does so by interacting both with Arp2/3 complex via the A region
and with G-actin via the WH2 region (4, 26). The interaction with
G-actin via the WH2 region confers a profilin-like function to the WA
domain, shuttling actin subunits to the growing barbed ends (9). In
addition, the WASp and N-WASp members of the WASp/Scar family contain a
CRIB domain that binds Cdc42 in the GTP-bound form (27-30). The
isolated full-length N-WASp molecule activates Arp2/3 to a lesser
extent than the WA domain; however, upon binding Cdc42 or
PIP2, N-WASp activates Arp2/3 in an enhanced fashion (6),
leading to a dramatic enhancement of actin polymerization in
vitro. This result suggested that the WA domain may be buried in
the N-WASp protein due to some internal interaction, and N-WASp would
switch to an active state, in which the WA domain is exposed, upon
binding Cdc42 or PIP2. Very recent NMR studies (31)
demonstrate that the so-called "cofilin-homology region" in the WA
domain of WASp interacts with the CRIB domain, in an autoinhibited
complex. Activation of N-WASp/Arp2/3 by the Shigella
flexneri bacterial pathogen has also been described (9). S. flexneri undergoes actin-based propulsion in host cells and is one
of the best tools for a molecular approach of actin-based motility.
Initiation of actin assembly at the surface of Shigella is
mediated by a single protein, IcsA (32), that harnesses N-WASp (33).
IcsA mimics Cdc42 in inducing a structural change in N-WASp, exposing
WA and stimulating Arp2/3-induced actin assembly and bacterial motility (9). The structural basis for activation of N-WASp by IcsA is not yet known.
The above results suggest that the function of WASp proteins in a
physiological context is to link Cdc42 activation to de novo
actin assembly. However, the activation of N-WASp may be driven by
other ligands binding to the proline-rich region of N-WASp via SH3
domains, such as the adaptors Grb2 and Nck (22, 23, 34, 35). The
SH2/SH3 adaptor Grb2 (36, 37) is conventionally considered to link the
tyrosine-phosphorylated EGF receptor (via its SH2 domain) and the Ras
guanine nucleotide exchange factor Sos (via its SH3 domains), without
affecting the nucleotide exchange function (38-42). On the other hand,
several studies suggest that Grb2 binds to a large number of other
targets (see Ref. 43 for a recent review), including proteins involved
in the organization of the actin cytoskeleton. Therefore, Grb2 could
act not only as an adaptor but also as an effector of
actin-dependent processes in response to signaling.
Microinjection of anti-Grb2 antibodies abolishes actin-based membrane
ruffling in response to EGF (44), binding of Grb2 to dynamin (45)
activates its GTPase activity (46), and inhibitors of the SH2 domain of
Grb2 block cell motility in hepatocyte growth factor-stimulated
Madin-Darby canine kidney cells (47). The role of these interactions in
the regulation of cytoskeletal reorganization has not been clearly
established; however, addition of Grb2 to cell lysates increases the
amount of N-WASp that coimmunoprecipitates with the activated EGF
receptor (23). Here we use in vitro actin polymerization
assays with pure Arp2/3 and N-WASp and motility assays of
Shigella in a medium reconstituted from pure proteins (3) to
show that Grb2 directly activates N-WASp and mediates Arp2/3
complex-dependent actin nucleation.
 |
MATERIALS AND METHODS |
Proteins--
Actin was purified from rabbit muscle and was
isolated as monomeric CaATP-G-actin by gel filtration in G buffer (5 mM Tris-Cl
, pH 7.8, 1 mM
dithiothreitol, 0.2 mM ATP, 0.1 mM
CaCl2, 0.01% NaN3) and pyrenyl-labeled as
described (48). Arp2/3 complex was purified from bovine brain (9).
Recombinant histidine-tagged human N-WASp was expressed in Sf21
cells using the baculovirus system (9). Profilin was purified from
bovine spleen (48). Recombinant Grb2 wild type was bacterially
expressed in Escherichia coli and purified (49). The P49L,
P206L, and G203R mutated forms of Grb2 were purified using a protocol
derived from Guilloteau et al. (49). Isolated N-terminal and
C-terminal SH3 domains of Grb2 were obtained by solid phase peptide
synthesis as described (50, 51). The Sos-derived peptide dimer
(VPPPVPPRRR-Aha-K-Aha-RRRPPVPPPV) was synthesized as described (52).
The SH2 domain binding phosphotyrosine m-arylphospho-Tyr-
-methylphospho-Tyr-Asn-NH2
tripeptide (pYpYN) was prepared as described (53). Recombinant Cdc42
was expressed, purified, and loaded with GTP
S as described (9).
Polymerization Assays--
Polymerization of actin was monitored
by the increase in fluorescence of pyrenyl-labeled actin. The assays
were carried out at 20 °C in a Spex fluorolog2 or a Safas flx
spectrofluorimeter. Samples (80 µl) contained typically 2.5 µM MgATP-G-actin (10% pyrenyl-labeled), 10-20
nM Arp2/3 complex, and N-WASp, Grb2, and other reagents as
indicated in F buffer (G buffer supplemented with 0.1 M KCl
and 1 mM MgCl2). The maximum slope of the
polymerization curves was taken as a measure of the activation of
Arp2/3 complex.
Modeling of the Kinetic Data in Terms of N-WASp Monomer-Dimer
Equilibrium--
N-WASp (W) was assumed to bind Arp2/3 (Y)
and Grb2 (X) and to associate into a dimer W2
with an equilibrium dissociation constant KD. The
different equilibria to be considered (Fig. 6) were described by the
following Equations 1-6.
|
(Eq. 1)
|
|
(Eq. 2)
|
|
(Eq. 3)
|
|
(Eq. 4)
|
|
(Eq. 5)
|
|
(Eq. 6)
|
The modeling of data shown in Fig. 2a was carried out
calculating the concentrations of WX, WY,
WXY, W2, and
W2Y2 and all other complexes as a
function of incremented W, using the above equations, which express
that ligands (X and Y) bind independently to
N-WASp. The total concentration of W was the sum of the concentrations of all the W containing species. It was considered that
[X]total = [X], i.e.
Grb2 is in large excess over all complexes of N-WASp and Arp2/3. The
value of Y was adjusted by iteration until the total
concentration of Y was exactly equal to the concentration of
Arp2/3 in the experiment. The value of [WY] + [WXY], which is the concentration of activated
N-WASp-Arp2/3 complex, carrying or not Grb2, was taken as representing
the activity measured in the polymerization assays.
Motility Assays of E. coli (IcsA)--
The effect of Grb2 on
actin-based movement of E. coli (IcsA), a good substitute
for Shigella (54), was tested by examining the motile
behavior of bacteria in the motility medium reconstituted from pure
proteins (3). Bacteria (6×109 bacteria/ml) were precoated
with N-WASp by preincubation in X buffer (20 mM HEPES, pH
7.5, 0.1 M KCl, 1 mM MgCl2, 0.2 mM CaCl2, 50 mM sucrose) containing
0.2 µM N-WASp and Grb2 as indicated, at 20 °C for 10 min. Bacteria were then sedimented at 13,000 × g for 4 min, resuspended in the original volume of X buffer, and diluted
30-fold in the motility medium. The motility medium consisted of 8 µM F-actin, 5 µM actin depolymerizing
factor, 50 nM Capping protein, 2.5 µM
profilin, and 0.1 µM Arp2/3 complex and was supplemented or not with Grb2 at the same concentration as in the preincubation step. Motility was observed in phase contrast optical microscopy as
described (3). The time course of generation of actin tails and
establishment of the steady rate of propulsion was monitored for each
sample, and the average rates were measured over at least 10 bacteria.
EDC/NHS Cross-linking of N-WASp--
N-WASp was equilibrated in
20 mM HEPES, 60 mM KCl buffer, pH 7.5, and
incubated at 1 µM with 5 mM EDC and 5 mM NHS for 45 min at 0 °C. Samples were immediately
denatured and submitted to SDS-PAGE (9% acrylamide),
electrotransferred onto nitrocellulose, and Western blotted using a
polyclonal anti-N-WASp at a 1:500 dilution (9) as primary antibody and
peroxidase-coupled anti-rabbit IgG as secondary antibody, followed by
ECL chemiluminescent detection (Amersham Pharmacia Biotech).
 |
RESULTS |
Grb2 Enhances the Interaction of N-WASp with Arp2/3, Leading to the
Stimulation of Actin Polymerization--
The binding of Cdc42-GTP
S
or of the Shigella protein IcsA to N-WASp leads to the
activation of actin polymerization by Arp2/3. The molecular mechanism
by which activated Arp2/3 complex induces the seemingly autocatalytic
polymerization of actin is not fully understood. The current
interpretation of the activation of Arp2/3 by N-WASp is that when
N-WASp binds effectors like Cdc42 or IcsA, the C-terminal WA domain of
N-WASp is exposed and is able to interact with Arp2/3 and G-actin to
stimulate actin filament nucleation and barbed end growth (6, 9). The
pyrene fluorescence assay for actin polymerization provides a rapid,
accurate, and quantitative test of the function of putative effectors
leading to the structural change and activation of N-WASp (or of
antagonists of this reaction).
The effect of Grb2, an SH3-SH2-SH3 multidomain adaptor, on the function
of N-WASp was addressed. Grb2 stimulated actin polymerization in the
presence of Arp2/3 complex and N-WASp (Fig.
1a). The effect of Grb2 was
maximum at a concentration of 1 µM, and half-effect was
observed at 0.1-0.2 µM (data not shown). Under
conditions of maximum activation, in the presence of 1 µM
Grb2, the N-WASp concentration dependence of the rate of actin
polymerization was consistent with the binding of Grb2·N-WASp complex
to Arp2/3 with an equilibrium dissociation constant of 5 nM
(Fig. 1b). In the absence of Grb2, however, the activity
measurements did not reflect normal saturation of Arp2/3 by N-WASp.
First, the half-maximum was obtained at a concentration of N-WASp
representing 25% of the Arp2/3 concentration. Second, activation of
polymerization first increased with N-WASp and then decreased at high
concentration (Fig. 2a).
Third, the percent activation provided by Grb2 increased with the
concentration of N-WASp (Fig. 2a, inset). The decrease in
activation of polymerization upon increasing N-WASp was observed in a
range of N-WASp concentration (0.1-0.8 µM) in which no
appreciable sequestration of G-actin by WA can occur. The two opposite
effects of N-WASp therefore suggest that N-WASp exists in two states
that can interact with Arp2/3. At low concentration
(10
9-10
8
M), N-WASp binds Arp2/3 in a complex that stimulates
polymerization, whereas at high concentration
(10
7-10
6
M) it also binds Arp2/3, but in a state that does not
stimulate polymerization. The stronger stimulating effect of Grb2 at
high N-WASp concentration suggests that Grb2 shifts N-WASp to its
active state. To get more insight into the possible association state of N-WASp and its control by Grb2, sedimentation velocity and cross-linking experiments were carried out. At 4 µM
N-WASp had a sedimentation coefficient
s20,w of 5.45 S. This value is much
higher than the one expected (3.98 S) for a monomeric 56-kDa globular
protein and is suggestive of a dimeric structure of N-WASp.
Cross-linking of N-WASp by EDC/NHS showed evidence for a triplet of
covalently cross-linked polypeptides migrating with apparent molecular
masses of 150-190 kDa in SDS-PAGE (Fig. 2b), supporting the
view that N-WASp is in a self-association equilibrium. The different
cross-linked species may correspond to different locations of the
cross-links in the amino acid sequence. The amount of cross-linked
polypeptides decreased in the presence of Grb2, suggesting that Grb2
stabilizes the monomeric form of N-WASp. No covalently cross-linked
Grb2-N-WASp polypeptide was detected. As will be discussed under
"Discussion," the polymerization data shown in Fig. 2a
are satisfactorily modeled (continuous line through the data
points) assuming that N-WASp undergoes self-association upon increasing
concentration and that the monomeric form activates actin
polymerization and is favored by Grb2 binding.

View larger version (26K):
[in this window]
[in a new window]
|
Fig. 1.
Grb2 activates N-WASp to stimulate actin
polymerization by Arp2/3 complex. a, activation of actin
assembly by Grb2 in the presence of Arp2/3 and N-WASp. MgATP-actin (2.5 µM, 10% pyrenyl-labeled) was polymerized in the presence
of 15 nM Arp2/3 alone (a) and with the following
additions: 42 nM N-WASp without (b) or with
(c) 0.75 µM Grb2. The polymerization process
is monitored by the increase in pyrenyl-actin fluorescence.
b, N-WASp interacts with Arp2/3 in a 1:1 complex in the
presence of Grb2. MgATP-actin (2.5 µM) was polymerized in
the presence of 18.5 nM Arp2/3 complex, 1.05 µM Grb2 and N-WASp at the indicated concentrations.
Inset, the maximum rate of polymerization was measured on
each curve and plotted versus the concentration of N-WASp. A
value of 5 nM was derived for the equilibrium dissociation
constant for binding of N-WASp to Arp2/3 in the presence of a
saturating amount of Grb2.
|
|

View larger version (28K):
[in this window]
[in a new window]
|
Fig. 2.
Structure-function relationship of N-WASp and
effect of Grb2. a, N-WASp concentration dependence of the
stimulation of actin polymerization. MgATP-G-actin (2.5 µM) was polymerized in the presence of 9 nM
Arp2/3 complex and N-WASp at the indicated concentrations, in the
absence (closed circles) or in the presence (open
circles) of 1 µM Grb2. The maximum rate of
polymerization is plotted versus the concentration of
N-WASp. Thin lines are theoretical curves obtained assuming
that N-WASp is in a reversible monomer-dimer equilibrium
(K = 90 nM); Arp2/3 binds equally well
monomeric and dimeric N-WASp, but only the monomeric species is active
in stimulating polymerization and binds Grb2 preferentially.
Inset, percent activation by Grb2 at different
concentrations of N-WASp (the line is the theoretical
curve). b, evidence for N-WASp self-association by covalent
cross-linking. N-WASp (1 µM) was incubated in the
presence of Grb2 at the indicated concentrations and submitted to
EDC/NHS cross-linking, followed by SDS-PAGE and Western blotting (see
"Materials and Methods").
|
|
Interaction of the C-terminal SH3 Domain of Grb2 with N-WASp Is
Responsible for the Stimulation of Actin Assembly by Arp2/3
Complex--
The above results suggest that one or both of the two SH3
domains of Grb2 activate N-WASp by binding to the proline-rich region of the protein. This possibility was tested using mutated forms of Grb2
and specific targets of the SH3 domains as follows (Fig. 3).

View larger version (25K):
[in this window]
[in a new window]
|
Fig. 3.
Effects of mutated forms of Grb2 and
inhibitors of Grb2 SH2 and SH3 domains on the activation of N-WASp.
A, MgATP-actin was polymerized at 2.5 µM
without additions or with 1.4 µM Grb2 (a), in
the presence of 11.5 nM Arp2/3 only (b), and in
the presence of Arp2/3 and the following additions: 1.4 µM Grb2 WT (c); 1.4 µM P49L-Grb2
(d); 42 nM N-WASp (e); 42 nM N-WASp and either 1.4 µM Grb2 wild type
(f) or 1.4 µM P49L-Grb2 (g); 42 nM N-WASp, 1.4 µM Grb2 wild type or P49L-Grb2
and 2.5 µM V33V peptidimer (h); 42 nM N-WASp and 2.5 µM V33V (i); 42 nM N-WASp and 2.5 µM pYpYN (j); 42 nM N-WASp, 1.4 µM Grb2, 2.5 µM
pYpYN (k); 42 nM N-WASp and 1 µM
G203R-Grb2 (l); 42 nM N-WASp and 1 µM P206L-Grb2 (m). B, schematic
representation of Grb2 with one SH2 domain between two SH3 domains.
Binding locations of pYpYN and V33V peptides are indicated. The
position of the three Grb2 mutations shows that P49L and P206L prevent
binding of the proline-rich peptides to the N-terminal and C-terminal
SH3 domains, respectively, whereas G203R is a structural interface
mutant. C, SDS-PAGE of the different proteins used in this
work. 1 µg each of the following proteins was electrophoresed on
SDS-15% acrylamide gels. Lane a, Grb2;
lane b, P49L-Grb2; lane c, P206L-Grb2; lane
d, G203R-Grb2; lane e, N-terminal SH3 domain of Grb2;
lane f, C-terminal SH3 domain of Grb2; lane
g, SH2 domain of Grb2; lane h, Cdc42.
|
|
First, the activating effect of Grb2 wild type (curve f in
Fig. 3A) was totally inhibited by 2.5 µM of
the Sos-derived peptide dimer VPPPVPPRRR-Aha-K-Aha-RRRPPVPPPV
(curve h in Fig. 3A), which binds both SH3
domains (Fig. 3B) and blocks the Ras signaling pathway (52).
The pYpYN phosphorylated tripeptide, which mimics the targets of the
SH2 domain of Grb2, caused a weak inhibition in the absence as well as
in the presence of Grb2. However, activation of N-WASp by Grb2 in
itself was not affected by pYpYN tripeptide (compare curves
j and k). In conclusion, the SH2 domain of Grb2 is not
responsible for the activation of N-WASp, and binding of the SH2 domain
of Grb2 to a phosphotyrosine peptide does not affect the affinity of
its SH3 domains for proline-rich targets, in agreement with Cussac
et al. (55).
The G203R point mutation in the C-terminal SH3 domain of Grb2 is
located at the interface of the two SH3 domains (Fig. 3B). It has been shown to impair sex myoblast migration (56). The G203R Grb2
mutant was totally unable to activate N-WASp (curve l in
Fig. 3A). This effect may be due to the arginine bulging off
the surface of the SH3 domain or to a local structural perturbation.
The P49L point mutation in the N-terminal SH3 domain of Grb2 is known
to greatly weaken the interaction between Grb2 and Sos (42). This
mutation is lethal in Caenorhabditis elegans (56). However,
the P49L Grb2 mutant activated N-WASp (curve g) with an
efficiency that varied, among different preparations, between 50 and
100% of the one observed with wild type Grb2. The effect was abolished
by the peptide dimer inhibitor. This result suggests that the
C-terminal domain of Grb2 is mainly responsible for its interaction
with and activation of N-WASp. In agreement with this conclusion, the
P206L point mutation in the C-terminal SH3 domain of Grb2 yielded a
protein that failed to activate N-WASp (curve m).
Control assays showed that Grb2 does not affect the polymerization of
actin alone and that in the absence of N-WASp, Grb2 and P49L Grb2
activate Arp2/3 to a small extent (curves c and d), indicating that in the overall complex comprising
N-WASp, Grb2, and Arp2/3, contacts exist between Arp2/3 and N-WASp,
Grb2 and N-WASp, and Grb2 and Arp2/3. A similar conclusion was reached concerning the activation of N-WASp by the Shigella protein
IcsA (9).
The activation of N-WASp by the isolated N-terminal and C-terminal SH3
domains of Grb2 was tested next. Fig. 4
shows that in the presence of 40 nM N-WASp, half-maximal
activation was observed with 0.25 and 2.5 µM C-terminal
and N-terminal SH3 domains, respectively. In conclusion, the C-terminal
domain of Grb2 activated N-WASp with an apparent affinity comparable to
that of Grb2 and about 10-fold higher than the N-terminal domain. This
result corroborates the conclusions derived from the studies with the
P49L and P206L Grb2 mutants. In contrast, in the association of Grb2
with Sos and with dynamin, the N-terminal SH3 domain of Grb2 was found to be the most efficient (57).

View larger version (22K):
[in this window]
[in a new window]
|
Fig. 4.
The C-terminal SH3 domain of Grb2 is more
efficient than the N-terminal SH3 domain to activate N-WASp.
MgATP-actin was polymerized at 2.5 µM in the presence of
18 nM Arp2/3 complex in the absence of N-WASp (control) and
in the presence of 31 nM N-WASp and either Grb2 C-terminal
SH3 domain (a) or Grb2 N-terminal domain (b) at
the indicated concentrations.
|
|
Finally, the isolated SH2 domain of Grb2 did not activate actin
polymerization in the presence of Arp2/3 and N-WASp. In contrast, a
concentration-dependent decrease in the rate of
polymerization was observed (data not shown). The inhibitory effect of
the SH2 domain was not abolished by the pYpYN peptide, which rules out the possibility that the inhibition be mediated by binding of SH2 to a
phospho-tyrosine motif in N-WASp.
Cdc42 and Grb2 Bind to N-WASp Simultaneously, Causing
Superactivation of Actin Polymerization--
Cdc42 binds to the CRIB
domain of N-WASp, and Grb2 binds the proline-rich region. Hence it is
theoretically possible that these two effectors of N-WASp, which both
independently activate the protein, bind simultaneously to the same
N-WASp molecule. This possibility was tested in the experiment shown in
Fig. 5. Actin was polymerized in the
presence of 20 nM Arp2/3, 30 nM N-WASp, and
saturating amounts (1 µM) of either Cdc42-GTP
S or Grb2
then in the presence of both effectors together. The same level of Arp2/3 activation was reached with either Grb2 or Cdc42-GTP
S. A
higher activation was obtained when both effectors were added together,
indicating that Grb2 and Cdc42 can be bound simultaneously to N-WASp
and that the structure/activity of the N-WASp molecule is different
when the two effectors are bound, allowing synergistic behavior.

View larger version (23K):
[in this window]
[in a new window]
|
Fig. 5.
Cdc42-GTP S and Grb2
bind simultaneously to N-WASp and activate actin polymerization
synergistically. MgATP-actin was polymerized at 2.5 µM in the presence of 18.5 nM Arp2/3 and the
following additions: none (a); 0.12 µM N-WASp
(b); 0.12 µM N-WASp and either 1 µM Grb2 or 2 µM Cdc42-GTP S, or 1 µM Grb2 and 2 µM Cdc42-GTP S as indicated
by the arrows.
|
|
Grb2 Promotes the Onset of Actin-based Motility of E. coli
(IcsA)--
The actin-based propulsion of E. coli (IcsA) is
acknowledged as a model for lamellipodium extension, which is suitable
for biochemical analysis, and has recently been reconstituted from a
set of pure proteins (3). The effect of Grb2 on actin-based motility of
E. coli (IcsA) was tested as described under "Materials and Methods." Briefly, bacteria were first preincubated in the presence of N-WASp to allow tight association of N-WASp with IcsA. N-WASp-coated bacteria were then placed in the motility medium. The
binding of N-WASp to IcsA at the surface of E. coli was not inhibited by the presence of Grb2 in the preincubation step. Both the
rate of propulsion and actin tail length were unchanged upon addition
of Grb2 to the motility medium. On the other hand, the time required
for bacteria to start moving, i.e. the pre-steady-state step, was shortened from 30 to 5 min when Grb2 was present at concentrations 1-4 µM in the N-WASp-precoating step.
These observations, summarized in Table
I, indicate first that Grb2 and IcsA do
not compete for binding to the same site on N-WASp. Second, the effect of Grb2 on the delay preceding the onset of movement appears linked to
the enhanced interaction between N-WASp and IcsA during the precoating
of E. coli (IcsA) by N-WASp, suggesting that, in stabilizing the active monomeric form of N-WASp, Grb2 facilitates the interaction of N-WASp with IcsA at the bacterium surface.
View this table:
[in this window]
[in a new window]
|
Table I
Effect of Grb2 on actin-based motility of E. coli (IcsA) in the
reconstituted motility assay
In the pre-coating step, bacteria were incubated for 15 min at room
temperature in the presence of 0.1 µM N-WASp and in the
absence or presence of Grb2 at the indicated concentration. Bacteria
were then centrifuged and resuspended in buffer before being placed in
the motility medium that was supplemented or not with Grb2 at the
indicated concentration. Samples were prepared for phase contrast
optical microscopy observation. The lag time before the onset of
movement was recorded. Rate measurements were performed as described
(3). The steady-state length of actin tails was about 20-30 µm in
all cases.
|
|
 |
DISCUSSION |
The present results show that in vitro the SH2/SH3
adaptor Grb2 acts as an effector of N-WASp, leading to the stimulation of actin assembly via N-WASp·Arp2/3 complex. The present data, involving sedimentation velocity, EDC cross-linking, together with the
concentration dependence of N-WASp activity in actin polymerization and
the effect of Grb2 on N-WASp·Arp2/3-mediated actin polymerization and
actin-based motility of E. coli (IcsA) suggest that the
structural basis for N-WASp activity involves at least a monomer-dimer
equilibrium, shifted toward the active monomer form by Grb2, according
to the minimum scheme displayed in Fig.
6. The data shown in Fig. 2a
could be satisfactorily accounted for by this scheme (see "Materials
and Methods" for detailed equations), assuming that 1) N-WASp
dimerizes with an equilibrium dissociation constant
KD of 90 nM; 2) Grb2 binds
preferentially monomeric N-WASp; 3) both monomeric and dimeric forms of
N-WASp bind Arp2/3 with the same affinity (KY = 5 nM), independently of Grb2 binding (Fig. 1b,
inset), but only the monomeric forms (N-WASp-Arp2/3 and
Grb2-N-WASp-Arp2/3) are active in filament branching. This model
explains why in the absence of Grb2 full activation of Arp2/3 is not
reached upon increasing N-WASp concentration; the formation of the
inactive Arp2/3-N-WASp dimer (W2Y2)
is thought to overlap the saturation of Arp2/3 by monomeric N-WASp.
Consistently, Grb2 is more effective at higher N-WASp concentration
(Fig. 2a, inset) because it is thought to shift the inactive
dimer toward the active monomer form. In the reports published so far,
it has been puzzling to observe quantitatively different effects of
IcsA and Cdc42 (9) on N-WASp-mediated activation of Arp2/3, as well as
additive effects of different ligands (Cdc42 and PIP2 (6);
Cdc42 and Grb2 in the present work). Such data are well accommodated by a monomer-dimer equilibrium of N-WASp that could be shifted to different extents to the active monomer form by ligand binding. The
proposal of regulation of N-WASp by self-association is not incompatible with the evidence for an interaction between peptides of
the C-terminal domain of N-WASp and peptides of the CRIB domain (26,
31). Such an interaction may take place via internal folding of a
monomer as well as via monomer-dimer interaction (or a higher degree of
self-association), as observed in Ezrin, another linker protein of the
cytoskeleton (58). However, only the self-association hypothesis can
account for the lower activity of N-WASp at high concentration reported
here (Fig. 2a). The present functional study is understood
as preliminary and calls for more extensive structural studies to
understand fully the regulation of N-WASp.

View larger version (11K):
[in this window]
[in a new window]
|
Fig. 6.
Thermodynamic scheme describing the
structural basis for N-WASp-Arp2/3 activation and its regulation by
Grb2. The model proposes that N-WASp (W) undergoes
monomer-dimer equilibrium 2W 232 W2, with
KD = 90 nM. Both monomer and dimer forms
bind Arp2/3 (Y) with the same affinity KY = 3 nM, and KYY = (KY)2. Only the complex of monomeric
N-WASp with Arp2/3 (WY) is active to stimulate actin
polymerization by filament branching. Grb2 (X) binds
preferentially the monomeric form of N-WASp with KX = 5 nM, and the dimeric form of N-WASp with a 32-fold lower
affinity (KXX = 5000 (nM)2).
The WX complex associates with Arp2/3 to form a
WXY active complex. The net effect of Grb2 on the
stimulation of actin polymerization is to increase the proportion of
N-WASp in the active monomer state (WXY). The active
complexes of monomeric N-WASp and Arp2/3 (WY and
WXY) are boxed.
|
|
Overall, our results give full biochemical/molecular support to the
view (44, 23, 47) that Grb2 may play a role in actin-based motility,
and they suggest that it could act also in vivo by
modulating the interaction between N-WASp and Arp2/3 complex. As
indicated by She et al. (23), Grb2 could mediate the motile
response of cells to EGF by directly linking the
tyrosine-phosphorylated EGF receptor to the N-WASp·Arp2/3 complex. In
addition to the PH and the CRIB domains, the proline-rich region of
N-WASp, which contains five consensus PPPPPXR motifs, now
appears to be another signal-responsive region of this fascinating
connector in actin-based motility. It is possible that the other
SH2/SH3 domain adaptor Nck, which has recently been demonstrated to be
involved in the recruitment of Arp2/3 complex in actin-based motility
of vaccinia virus (35), activates N-WASp like Grb2 to elicit actin tail
formation. Whether the interaction of N-WASp with the SH3 domains of
the tyrosine kinases Fgr or Fyn regulates N-WASp function is an open issue.
In the absence of N-WASp, Grb2 elicited a weak activation of Arp2/3. It
is possible that the ridge of negatively charged amino acids created by
the relative positions of the two SH3 domains at the surface of Grb2
participates in electrostatic interactions with Arp2/3 complex, like
the acidic C terminus of N-WASp, resulting in stimulation of the
nucleating activity. A similar observation has been made with IcsA
(9).
Use of mutated forms of Grb2, of specific inhibitors of SH2 and SH3
domains, and of the isolated N-terminal and C-terminal SH3 domains of
Grb2 demonstrates that the C-terminal SH3 domain of Grb2 is the main
active target of the proline-rich region on N-WASp. This result is
surprising when compared with binding studies of Grb2 to the homologous
WASp (23), which indicated that the N-terminal SH3 domain of Grb2 bound
slightly more strongly than the C-terminal SH3 domain. This discrepancy
may be due either to differences in the proline-rich regions of WASp
and N-WASp or to the difference in the methods used. Binding studies
relied on pull down assays of WASp from whole cell lysates of
hemagglutinin-WASp-transfected kidney cells using glutathione
S-transferase fusion proteins coupled to glutathione-agarose
beads, and here the biological activity of pure proteins or isolated
domains was measured.
The physiological significance of multiple SH3 domains in adaptors like
Grb2 (two SH3 domains) or Nck (three SH3 domains) has been discussed
(43, 57). It is generally thought that the presence of several SH3
domains strengthens the binding of the whole protein, even though
individual SH3 domains may display differential affinity. The
N-terminal SH3 domain of Grb2 is the only one that is essential in
mediating high affinity binding to dynamin (54), and it displays a
predominant contribution in binding to Sos (37, 39), whereas here it is
the C-terminal SH3 domain of Grb2 that plays a predominant role in
activation of N-WASp. The two SH3 domains of Grb2 may interact
differentially in different signaling pathways, making Grb2 a highly
versatile adaptor. Our results suggest that transfection of cells with
the P49L Grb2 mutant, which blocks the Ras signaling pathway, should not inhibit the function of Grb2 in actin-based motility.
The N-WASp molecule can be activated by Cdc42 and Grb2 in a synergistic
fashion. Similarly, PIP2 and Cdc42 have been shown to
cooperate in activating N-WASp (6). These results support the view that
the multidomain organization of N-WASp has functional significance.
PIP2 and Grb2 also cooperate in activation of dynamin GTPase (43).
The possible regulation of the activity of N-WASp in vivo by
Grb2 is an open issue. Since both Grb2 and N-WASp are soluble proteins,
the simple in vitro approach suggests that Grb2 could activate N-WASp and stimulate actin polymerization in the cytosol, whereas in principle in the cell N-WASp is activated at the plasma membrane by signaling. It is possible that in the in vivo
context, the cytosolic N-WASp is maintained inactive, perhaps in a
self-associated form, and is unable to bind Grb2, and it binds Grb2
when it is recruited to the membrane by other effectors. The possible
regulation of N-WASp by phosphorylation of a tyrosine in the N-terminal
domain has not been considered yet. Further mutagenesis and biochemical and structural studies of N-WASp are required to understand fully the
complex behavior of this important connector between signaling molecules and actin.
 |
ACKNOWLEDGEMENTS |
We are very grateful to Dominique Didry for
assistance in actin, N-WASp, and Arp2/3 preparation and discussions and
W. Q. Liu, F. Cornille, and C. Lenoir from Professor Roques's
laboratory for the chemical synthesis of the N- and C-terminal SH3
domains of Grb2.
 |
FOOTNOTES |
*
This work was supported in part by the Association pour la
Recherche Contre le Cancer, the Association Française Contre les Myopathies, and by Human Frontiers in Science Grant RG 227/98.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
§
To whom correspondence should be addressed. Tel.: 33 01 69 82 34 65; Fax: 33 01 69 82 31 29; E-mail: carlier@lebs.cnrs-gif.fr.
Supported by the Ligue Nationale Française contre le Cancer.
Published, JBC Papers in Press, April 25, 2000, DOI 10.1074/jbc.M000687200
 |
ABBREVIATIONS |
The abbreviations used are:
WASp, Wiskott-Aldrich Syndrome protein;
N-WASp, neural Wiskott-Aldrich
Syndrome protein;
PH, pleckstrin homology;
WH1, WASp homology 1;
PIP2, phosphatidylinositol bisphosphate;
EGF, epidermal
growth factor;
EDC, 1-ethyl-3-(3-dimethyl aminopropyl) carbodiimide;
NHS, N-hydroxysuccinimide;
GTP
S, guanosine
5'-3-O-(thio)triphosphate;
PAGE, polyacrylamide gel
electrophoresis;
WA, WH2-Acidic;
Aha, aminohexanoic acid.
 |
REFERENCES |
| 1.
|
Machesky, L. M.,
and Insall, R. H.
(1999)
J. Cell Biol.
146,
267-272
|
| 2.
|
Carlier, M.-F.,
Ducruix, A.,
and Pantaloni, D.
(1999)
Chem. Biol.
6,
R235-R239
|
| 3.
|
Loisel, T. P.,
Boujemaa, R.,
Pantaloni, D.,
and Carlier, M.-F.
(1999)
Nature
401,
613-616
|
| 4.
|
Machesky, L. M.,
and Insall, R. H.
(1998)
Curr. Biol.
8,
1347-1356
|
| 5.
|
Machesky, L. M.,
Mullins, R. D.,
Higgs, H. N.,
Kaiser, D. A.,
Blanchoin, L.,
May, R. C.,
Hall, M. E.,
and Pollard, T. D.
(1999)
Proc. Natl. Acad. Sci. U. S. A.
96,
3739-3744
|
| 6.
|
Rohatgi, R. L.,
Ma, L.,
Miki, H.,
Lopez, M.,
Kirchhausen, T.,
Takenawa, T.,
and Kirschner, M. W.
(1999)
Cell
97,
221-231
|
| 7.
|
Winter, D.,
Lechler, T.,
and Li, R.
(1999)
Curr. Biol.
9,
501-504
|
| 8.
|
Yarar, D.,
To, W.,
Abo, A.,
and Welch, M. D.
(1999)
Curr. Biol.
9,
555-558
|
| 9.
|
Egile, C.,
Loisel, T. P.,
Laurent, V.,
Pantaloni, D.,
Sansonetti, P. J.,
and Carlier, M.-F.
(1999)
J. Cell Biol.
146,
1319-1332
|
| 10.
|
Bi, E.,
and Zigmond, S. H.
(1999)
Curr. Biol.
9,
R160-R163
|
| 11.
|
Miki, H.,
Sasaki, T.,
Takai, Y.,
and Takenawa, T.
(1998)
Nature
391,
93-96
|
| 12.
|
Miki, H.,
Suetsugu, S.,
and Takenawa, T.
(1998)
EMBO J.
17,
6932-6941
|
| 13.
|
Linder, S.,
Nelson, D.,
Weiss, M.,
and Aepfelbacher, M.
(1999)
Proc. Natl. Acad. Sci. U. S. A.
96,
9648-9653
|
| 14.
|
Derry, J. M.,
Ochs, H. D.,
and Francke, U.
(1994)
Cell
78,
635-644
|
| 15.
|
Miki, H.,
Miura, K.,
and Takenawa, T.
(1996)
EMBO J.
15,
5326-5335
|
| 16.
|
Li, R.
(1997)
J. Cell Biol.
136,
649-658
|
| 17.
|
Bear, J. E.,
Rawls, J. F.,
and Saxe, C. L., III
(1998)
J. Cell Biol.
142,
1325-1335
|
| 18.
|
Ramesh, N.,
Anton, I. M.,
Hartwig, J. H.,
and Geha, R. S.
(1997)
Proc. Natl. Acad. Sci. U. S. A.
94,
14671-14676
|
| 19.
|
Naqvi, S. N.,
Zahn, R.,
Mitchell, D. A.,
Stevenson, B. J.,
and Munn, A. L.
(1998)
Curr. Biol.
8,
959-962
|
| 20.
|
Vaduva, G.,
Martinez-Quiles, N.,
Anton, I. M.,
Martin, N. C.,
Geha, R. S.,
Hopper, A. K.,
and Ramesh, N.
(1999)
J. Biol. Chem.
274,
17103-17108
|
| 21.
|
Rivero-Lezcano, O. M.,
Marcilla, A.,
Sameshima, J. H.,
and Robbins, K. C.
(1995)
Mol. Cell. Biol.
15,
5725-5731
|
| 22.
|
Banin, S.,
Truong, O.,
Katz, D. R.,
Waterfield, M. D.,
Brickell, P. M.,
and Gout, I.
(1996)
Curr. Biol.
6,
981-988
|
| 23.
|
She, H.-Y.,
Rockow, S.,
Tang, J.,
Nishimura, R.,
Skolnik, E. Y.,
Chen, M.,
Margolis, B.,
and Li, W.
(1997)
Mol. Biol. Cell
8,
1709-1720
|
| 24.
|
Miki, H.,
Fukuda, M.,
Nishida, E.,
and Takenawa, T.
(1999)
J. Biol. Chem.
274,
27605-27609
|
| 25.
|
Ramesh, N.,
Anton, I. M.,
Martinez-Quiles, N.,
and Geha, R. S.
(1999)
Trends Cell Biol.
9,
15-19
|
| 26.
|
Miki, H.,
and Takenawa, T.
(1998)
Biochem. Biophys. Res. Commun.
243,
73-78
|
| 27.
|
Aspenström, P.,
Lindberg, U.,
and Hall, A.
(1996)
Curr. Biol.
6,
70-75
|
| 28.
|
Symons, M.,
Derry, J. M.,
Karlak, B.,
Jiang, S.,
Lemahieu, V.,
Mccormick, F.,
Francke, U.,
and Abo, A.
(1996)
Cell
84,
723-734
|
| 29.
|
Kolluri, R. S.,
Tolias, K. F.,
Carpenter, C. L.,
Rosen, F. S.,
and Kirchhausen, T.
(1996)
Proc. Natl. Acad. Sci. U. S. A.
93,
5615-5618
|
| 30.
|
Abdul-Manan, N.,
Aghazadeh, B.,
Liu, G. A.,
Majumdar, A.,
Ouerfelli, O.,
Siminovitch, K. A.,
and Rosen, M. K.
(1999)
Nature
399,
379-383
|
| 31.
|
Kim, A. S.,
Kakalis, L. T.,
Abdul-Mananb, N.,
Liu, G. A.,
and Rosen, M. K.
(2000)
Nature
404,
151-158
|
| 32.
|
Bernardini, M. L.,
Mounier, J.,
d'Hauteville, H.,
Coquis-Rondon, M.,
and Sansonetti, P.
(1989)
Proc. Natl. Acad. Sci. U. S. A.
86,
3867-3871
|
| 33.
|
Suzuki, T.,
Miki, H.,
Takenawa, T.,
and Sasakawa, C.
(1998)
EMBO J.
17,
2767-2776
|
| 34.
|
Stewart, D. M.,
Treiber-Held, S.,
Kurman, C. C.,
Facchetti, F.,
Notarangelo, L. D.,
and Nelson, D. L.
(1996)
J. Clin. Invest.
97,
2627-2633
|
| 35.
|
Frischknecht, F.,
Moreau, V.,
Röttger, S.,
Gonfloni, S.,
Reckman, I.,
Superti-Fuga, G.,
and Way, M.
(1999)
Nature
401,
926-929
|
| 36.
|
Maignan, S.,
Guilloteau, J. P.,
Fromage, N.,
Arnoux, B.,
Becquart, J.,
and Ducruix, A.
(1995)
Science
268,
291-293
|
| 37.
|
Chardin, P.,
Cussac, D.,
Maignan, S.,
and Ducruix, A.
(1995)
FEBS Lett.
369,
47-51
|
| 38.
|
Buday, L.,
and Downward, J.
(1993)
Cell
73,
611-620
|
| 39.
|
Egan, S. E.,
Giddings, B. W.,
Brooks, M. W.,
Buday, L.,
Sizeland, A. M.,
and Weinberg, R. A.
(1993)
Nature
363,
45-51
|
| 40.
|
Li, N.,
Batzer, A.,
Daly, R.,
Yajnik, V.,
Skolnik, E.,
Chardin, P.,
Bar-Sagi, D.,
Margolis, B.,
and Schlessinger, J.
(1993)
Nature
363,
85-88
|
| 41.
|
Gale, N. W.,
Kaplan, S.,
Lowenstein, E. J.,
Schlessinger, J.,
and Bar-Sagi, D.
(1993)
Nature
363,
88-92
|
| 42.
|
Rozackis-Adcock, M.,
Fernley, R.,
Wade, J.,
Pawson, T.,
and Bowtell, D.
(1993)
Nature
363,
83-85
|
| 43.
|
Buday, L.
(1999)
Biochim. Biophys. Acta
1422,
187-204
|
| 44.
|
Matuoka, K.,
Shibasaki, F.,
Shibata, M.,
and Takenawa, T.
(1993)
EMBO J.
12,
3464-3473
|
| 45.
|
Wang, Z.,
and Moran, M. F.
(1996)
Science
272,
1935-1938
|
| 46.
|
Barylko, B.,
Binns, D.,
Lin, K. M.,
Atkinson, M. A.,
Jameson, D. M.,
Yin, H. L.,
and Albanesi, J. P.
(1998)
J. Biol. Chem.
273,
3791-3797
|
| 47.
|
Gay, B.,
Suarez, S.,
Weber, C.,
Rahuel, J.,
Fabbro, D.,
Furet, P.,
Caravatti, G.,
and Schoepfer, J.
(1999)
J. Biol. Chem.
274,
23311-23315
|
| 48.
|
Pantaloni, D.,
and Carlier, M.-F.
(1993)
Cell
75,
1007-1014
|
| 49.
|
Guilloteau, J. P.,
Fromage, N.,
Ries-Kautt, M.,
Reboul, S.,
Bocquet, D.,
Dubois, H.,
Faucher, D.,
Colonna, C.,
Ducruix, A.,
and Becquart, J.
(1999)
Proteins Struct. Funct. Genet.
25,
112-119
|
| 50.
|
Goudreau, N.,
Cornille, F.,
Duchesne, M.,
Parker, F.,
Tocqué, B.,
Garbay, C.,
and Roques, B. P.
(1994)
Struct. Biol.
1,
898-902
|
| 51.
|
Kohda, D.,
Teresawa, H.,
Ichikawa, S.,
Ogura, K.,
Hatanaka, H.,
Mandiyan, V.,
Ullrich, A.,
Schlessinger, J.,
and Inagaki, F.
(1994)
Structure
2,
1029-1040
|
| 52.
|
Cussac, D.,
Vidal, M.,
Leprince, C.,
Liu, W. Q.,
Cornille, F.,
Tiraboschi, G.,
Roques, B. P.,
and Garbay, C.
(1999)
FASEB J.
13,
31-39
|
| 53.
|
Liu, W. Q.,
Vidal, M.,
Gresh, N.,
Roques, B. P.,
and Garbay, C.
(1999)
J. Med. Chem.
42,
3737-3741
|
| 54.
|
Kocks, C.,
Marchand, J.-B.,
Gouin, E.,
d'Hauteville, H.,
Sansonetti, P.,
Carlier, M.-F.,
and Cossart, P.
(1995)
Mol. Microbiol.
18,
413-423
|
| 55.
|
Cussac, D.,
Frech, M.,
and Chardin, P.
(1994)
EMBO J.
13,
4011-4021
|
| 56.
|
Clark, S. G.,
Stern, M. J.,
and Horvitz, H. R.
(1992)
Nature
356,
340-344
|
| 57.
|
Vidal, M.,
Goudreau, N.,
Cornille, F.,
Cussac, D.,
Gincel, E.,
and Garbay, C.
(1999)
J. Mol. Biol.
290,
717-730
|
| 58.
|
Bretscher, A.,
Gary, R.,
and Berryman, M.
(1995)
Biochemistry
34,
16830-16837
|
Copyright © 2000 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
C. Le Clainche and M.-F. Carlier
Regulation of Actin Assembly Associated With Protrusion and Adhesion in Cell Migration
Physiol Rev,
April 1, 2008;
88(2):
489 - 513.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Garg, R. Verma, D. Nihalani, D. B. Johnstone, and L. B. Holzman
Neph1 Cooperates with Nephrin To Transduce a Signal That Induces Actin Polymerization
Mol. Cell. Biol.,
December 15, 2007;
27(24):
8698 - 8712.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Y. W. Bourguignon, K. Peyrollier, E. Gilad, and A. Brightman
Hyaluronan-CD44 Interaction with Neural Wiskott-Aldrich Syndrome Protein (N-WASP) Promotes Actin Polymerization and ErbB2 Activation Leading to beta-Catenin Nuclear Translocation, Transcriptional Up-regulation, and Cell Migration in Ovarian Tumor Cells
J. Biol. Chem.,
January 12, 2007;
282(2):
1265 - 1280.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Le Clainche, D. Schlaepfer, A. Ferrari, M. Klingauf, K. Grohmanova, A. Veligodskiy, D. Didry, D. Le, C. Egile, M.-F. Carlier, et al.
IQGAP1 Stimulates Actin Assembly through the N-Wasp-Arp2/3 Pathway
J. Biol. Chem.,
January 5, 2007;
282(1):
426 - 435.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. M. Kovacs, R. S. Makar, and F. B. Gertler
Tuba stimulates intracellular N-WASP-dependent actin assembly
J. Cell Sci.,
July 1, 2006;
119(13):
2715 - 2726.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Krzewski, X. Chen, J. S. Orange, and J. L. Strominger
Formation of a WIP-, WASp-, actin-, and myosin IIA-containing multiprotein complex in activated NK cells and its alteration by KIR inhibitory signaling.
J. Cell Biol.,
April 10, 2006;
173(1):
121 - 132.
[Abstract]
[Full Text]
[PDF]
|
 |
|